Joo-yeon Lee

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

A Rapid Detection of Nipah Virus Nucleocapsid Antigen in Inactivated Viral Cultures.

A Rapid Detection of Nipah Virus Nucleocapsid Antigen in Inactivated Viral Cultures.

Journal: Emerging microbes & infections
Published: August 07, 2026

Bioprocess Development of a Human Monoclonal Antibody against MERS-CoV: Analytical and Preclinical Studies.

Bioprocess Development of a Human Monoclonal Antibody against MERS-CoV: Analytical and Preclinical Studies.

Journal: Biomolecules & therapeutics
Published: January 02, 2026

Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2.

Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2.

Journal: Journal of medical virology
Published: December 19, 2025

QStrain: an interactive platform for viral genome analysis and nucleic acid therapeutic design.

QStrain: an interactive platform for viral genome analysis and nucleic acid therapeutic design.

Journal: BMC bioinformatics
Published: November 26, 2025

Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus-A Prospective Real-World Cohort Study.

Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus-A Prospective Real-World Cohort Study.

Journal: The Journal of infectious diseases
Published: June 15, 2025

Forecasting framework for dominant SARS-CoV-2 strains before clade replacement using phylogeny-informed genetic distances.

Forecasting framework for dominant SARS-CoV-2 strains before clade replacement using phylogeny-informed genetic distances.

Journal: Frontiers in microbiology
Published: April 28, 2025

Development of Plant-Based Multivalent Vaccine Candidates for SARS-CoV-2 and Influenza Virus Using Inactivated Lactococcus.

Development of Plant-Based Multivalent Vaccine Candidates for SARS-CoV-2 and Influenza Virus Using Inactivated Lactococcus.

Journal: Vaccines
Published: January 13, 2025

Predicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach.

Predicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach.

Journal: Infectious diseases (London, England)
Published: January 03, 2025

A Novel Antibody Against the Non-Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein.

A Novel Antibody Against the Non-Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein.

Journal: The Journal of infectious diseases
Published: October 24, 2024

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.

Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.

Journal: Experimental & molecular medicine
Published: September 03, 2024

Reinfection of SARS-CoV-2 Variants in Immunocompromised Patients with Prolonged or Relapsed Viral Shedding.

Reinfection of SARS-CoV-2 Variants in Immunocompromised Patients with Prolonged or Relapsed Viral Shedding.

Journal: Infection & chemotherapy
Published: August 21, 2024

The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation.

The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation.

Journal: Science signaling
Published: August 20, 2024
Showing 1-12 of 74

Last Updated: 09/26/2026